Active Ingredient History

NOW
  • Now
Vocimagene amiretrorepvec/flucytosine is an experimental combination drug involving a gene therapy agent and a prodrug. It is a candidate drug to treat brain cancers.   Wikipedia

More Chemistry
toca 511 | toca-511 | vocimagene amiretrorepvec

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue